Digital Innovation of the Year

Short description

The development of next generation cancer treatments benefits from the quantum leap advancements in data collection and data analytics. Our digital solution initiative accelerates development and democratization of personalized medicinal products.
 

Jury Statement

Precision medicine: T cell-based cancer therapies are coming out of infancy with CAR T therapies for liquid tumours (leukemia) approved since 2017 and with some 25’000 patients treated globally since. Tigen digital innovation will help to secure the new data supply chain from patient to producer of cancer cure for designing personalized solution fot the patient.